9 May 2024
Warpaint London PLC
("Warpaint", the "Company" or the "Group")
BLOCK LISTING INTERIM RETURN
Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, gives the below information required by Schedule 6 of the AIM Rules for Companies in connection with the Warpaint London plc Company Share Option Plan (2020).
Name of applicant: |
Warpaint London PLC |
|||
Name of scheme: |
Warpaint London plc Company Share Option Plan (2020) |
|||
Period of return: |
From: |
9 November 2023 |
To: |
9 May 2024 |
Balance under scheme from previous return: |
385,633 Ordinary Shares |
|||
The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: |
N/A |
|||
Number of securities issued/allotted under scheme during period: |
375,633 Ordinary Shares
|
|||
Balance under scheme not yet issued/allotted at end of period |
10,000 Ordinary Shares |
|||
Number and class of securities originally listed and the date of admission |
385,633 Ordinary Shares on 9 May 2023 |
|||
Total number of securities in issue at the end of the period |
77,342,723 Ordinary Shares |
|||
Name of contact: |
Neil Rodol |
|||
Telephone number of contact: |
As below |
|||
Enquiries:
Warpaint London Sam Bazini - Chief Executive Officer Eoin Macleod - Managing Director Neil Rodol - Chief Financial Officer |
c/o IFC
|
|
Shore Capital (Nominated Adviser & Broker) Patrick Castle, Daniel Bush - Corporate Advisory Fiona Conroy - Corporate Broking
|
020 7408 4090 |
|
IFC Advisory (Financial PR & IR) Tim Metcalfe, Graham Herring, Florence Chandler |
020 3934 6630
|
Warpaint London plc
Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.